Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1390

Bimagrumab

Home » Bimagrumab

Background of Bimagrumab

Bimagrumab-(BYM338)-is-a-fully-human-monoclonal-antibody-developed-by-Novartis,-primarily-targeting-the-activin-receptor-type-2B-(ActRIIB).-This-antibody-is-designed-to-treat-conditions-associated-with-muscle-loss-and-weakness,-such-as-sarcopenia-and-obesity-related-metabolic-disorders.-By-inhibiting-the-binding-of-natural-ligands-to-ActRIIB,-bimagrumab-promotes-muscle-hypertrophy-and-reduces-fat-mass,-making-it-a-potential-therapeutic-option-for-various-muscle-wasting-conditions.

Specifications

Catalog Number:
KB-1390
Antibody Name:
Bimagrumab
Isotype:
Human IgG1,lambda
FC Muations:
Wild-Type
Target:
ACVR2A&ACVR2B
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
ELISA
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C;Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Johanna-M,Laura-V,Teemu-K,et.al.Systemic-Blockade-of-ACVR2B-Ligands-Protects-Myocardium-from-Acute-Ischemia-Reperfusion-Injury.Mol-Ther-2019;27(3):600-610.
  2. Oddrun-Elise-Olsen,Karin-Fahl-Wader,Hanne-Hella,et.al.Activin-A-inhibits-BMP-signaling-by-binding-ACVR2A-and-ACVR2B.Cell-Commun-Signal-2015;13(27).
  3. Julia-S,Zoltan-Szabo,Juliana-Peter,et.al.Inhibition-of-activin-receptor-2-signalling-ameliorates-metabolic-dysfunction–associated-steatotic-liver-disease-in-western-diet/L-NAME-induced-cardiometabolic-disease.Biomedicine&Pharmacotherapy-2024;175.